Jonathan Kimmelman is an Associate Professor at the Biomedical Ethics Unit / Social Studies of Medicine at McGill. He has cross appointments in Experimental Medicine, Epidemiology, Biostatistics and Occupational Health and Human Genetics. His research centres on the ethical, social and policy challenges in testing novel medical technologies in human beings, known as translational clinical research. Current projects are investigating risk, prediction, validity and knowledge value across the trajectory of drug development. From 2008-2010, he chaired the ethics committee of the American Society of Gene and Cell Therapy and currently chairs the ethics committee of the International Society of Stem Cell Research. Jonathan also directs the Group Studies of Translation, Ethics and Medicine (STREAM). Jonathan holds a Ph.D. in Molecular Biophysics and Biochemistry from Yale University. He received the Institute of Genetics Maud Menten New Investigator Prize, a CIHR New Investigator Award (2008) and a Friedrich Bessel-Humboldt Award (2014).